Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Dolak

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Biochemistry International|October 1, 1984
Abnormalities of splenic enzyme networks in nude miceT Aoyagi, T Wada, L A Dolak, et al.
The Journal of Antibiotics|November 1, 1983
Fermentation, isolation, characterization and structure of nitrosofunginL A Dolak, T M Castle, B R Hannon, et al.
The Journal of Antibiotics|February 1, 1987
Enzymatic phosphorylation of macrolide antibioticsP F Wiley, L Baczynskyj, L A Dolak, et al.
The Journal of Antibiotics|January 1, 1983
Desertomycin: purification and physical-chemical propertiesL A Dolak, F Reusser, L Baczynskyj, et al.
Experientia|April 15, 1996
The amphiphilic properties of novenamines determine their activity as inhibitors of HIV-1 RNase HI W Althaus, K M Franks, K B Langley, et al.
Journal of Medicinal Chemistry|September 1, 1995
Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitorsS Thaisrivongs, K D Watenpaugh, W J Howe, et al.
Journal of Medicinal Chemistry|December 22, 1995
Structure-based design of sulfonamide-substituted non-peptidic HIV protease inhibitorsH I Skulnick, P D Johnson, W J Howe, et al.
Journal of Medicinal Chemistry|June 7, 1996
Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitorsS Thaisrivongs, M N Janakiraman, K T Chong, et al.
Journal of Medicinal Chemistry|February 28, 1997
Synthesis and biological activities of (R)-5,6-dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine and its metabolitesR F Heier, L A Dolak, J N Duncan, et al.
Bioorganic & Medicinal Chemistry|November 17, 2001
Carbon-carbon-linked (pyrazolylphenyl)oxazolidinones with antibacterial activity against multiple drug resistant gram-positive and fastidious gram-negative bacteriaC S Lee, D A Allwine, M R Barbachyn, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Biochemistry International|October 1, 1984
Abnormalities of splenic enzyme networks in nude miceT Aoyagi, T Wada, L A Dolak, et al.
The Journal of Antibiotics|November 1, 1983
Fermentation, isolation, characterization and structure of nitrosofunginL A Dolak, T M Castle, B R Hannon, et al.
The Journal of Antibiotics|February 1, 1987
Enzymatic phosphorylation of macrolide antibioticsP F Wiley, L Baczynskyj, L A Dolak, et al.
The Journal of Antibiotics|January 1, 1983
Desertomycin: purification and physical-chemical propertiesL A Dolak, F Reusser, L Baczynskyj, et al.
Experientia|April 15, 1996
The amphiphilic properties of novenamines determine their activity as inhibitors of HIV-1 RNase HI W Althaus, K M Franks, K B Langley, et al.
Journal of Medicinal Chemistry|September 1, 1995
Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitorsS Thaisrivongs, K D Watenpaugh, W J Howe, et al.
Journal of Medicinal Chemistry|December 22, 1995
Structure-based design of sulfonamide-substituted non-peptidic HIV protease inhibitorsH I Skulnick, P D Johnson, W J Howe, et al.
Journal of Medicinal Chemistry|June 7, 1996
Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitorsS Thaisrivongs, M N Janakiraman, K T Chong, et al.
Journal of Medicinal Chemistry|February 28, 1997
Synthesis and biological activities of (R)-5,6-dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine and its metabolitesR F Heier, L A Dolak, J N Duncan, et al.
Bioorganic & Medicinal Chemistry|November 17, 2001
Carbon-carbon-linked (pyrazolylphenyl)oxazolidinones with antibacterial activity against multiple drug resistant gram-positive and fastidious gram-negative bacteriaC S Lee, D A Allwine, M R Barbachyn, et al.
Pageof 3